SCHEMBL8488299

SCHEMBL8488299

COC(=O)C(CCBr)c1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 4/20 0.46
SLC6A3 Q01959 2/20 0.45
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
RECQL P46063 1/20 0.44
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43
EDNRA P25101 1/20 0.43
MMP9 P14780 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5829437 0.84 SLC6A3 (0.48) SLC6A3MTNR1AMTNR1BRECQLPPARG
SCHEMBL31170906 0.84 SLC6A3 (0.48) SLC6A3MTNR1AMTNR1BRECQLPPARG
SCHEMBL7398621 0.82 ROCK2 (0.51) SLC6A3RECQLPPARGPPARDPPARA
SCHEMBL5257603 0.82 KMT2A (0.55) MTNR1AMTNR1B
SCHEMBL28595878 0.80 MTNR1A (0.46) UTS2RSLC6A3MTNR1AMTNR1BAKR1C3
SCHEMBL19986352 0.80 SLC6A3 (0.51) UTS2RSLC6A3EDNRA
SCHEMBL631558 0.78 SLC6A3 (0.50) SLC6A3
SCHEMBL28601751 0.78 MTNR1A (0.46) UTS2RSLC6A3MTNR1AMTNR1B
SCHEMBL7336112 0.77 SLC6A3 (0.50) SLC6A3RECQLPPARGPPARDPPARA
SCHEMBL30992200 0.77 SLC6A3 (0.45) SLC6A3RECQLPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed